STOCK TITAN
  1. Home
  2. Sec-filings
  3. XAIR
  4. [EFFECT] Beyond Air, Inc. SEC Filing

[EFFECT] Beyond Air, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 9, 2026 5:00 P.M.
Form: S-3
CIK: 0001641631
Company Name: Beyond Air, Inc.
File Number: 333-293075

Source: View Original Filing on SEC EDGAR

Stock XAIR logo
Beyond Air Inc

NASDAQ:XAIR

XAIR Rankings

#6270 Ranked by Market Cap
N/A Ranked by Dividends

XAIR Latest News

Feb 4, 2026
Beyond Cancer Abstract Featuring Phase 1 Data on Intratumoral Ultra-High Concentration Nitric Oxide (UNO) in Solid Tumor Metastases to be Presented at the AACR Annual Meeting 2026
Jan 27, 2026
Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences
Jan 26, 2026
Beyond Air Schedules Third Fiscal Quarter 2026 Financial Results Conference Call and Webcast
Jan 14, 2026
Beyond Air Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Jan 13, 2026
XTL Biopharmaceuticals Acquires 85% of Beyond Air’s Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

XAIR Latest SEC Filings

Feb 10, 2026
[424B3] Beyond Air, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Feb 2, 2026
[8-K] Beyond Air, Inc. Reports Material Event
Jan 30, 2026
[S-3] Beyond Air, Inc. Shelf Registration Statement
Jan 20, 2026
[8-K] Beyond Air, Inc. Reports Material Event
Jan 6, 2026
[Form 4] Beyond Air, Inc. Insider Trading Activity

XAIR Stock Data

12.11M
17.40M
11.57%
10.53%
6.12%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
GARDEN CITY